Clinical Trial Update: Rosiglitazone to Treat Patients With Heart Failure and Glucose Intolerance or Type II Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating rosiglitazone in patients with congestive heart failure and glucose intolerance or type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucose Intolerance
• Heart Failure
• Type 2 Diabetes Mellitus

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Congestive Heart Failure | Phase 2 | Status: COMPLETED